Awards

Iris Baumgartner, MD

Iris Baumgartner, MD, is an internationally recognized specialist in Internal Medicine and Angiology, focusing on endovascular therapy for the treatment of arterial and venous diseases, as well as vascular malformations.

Originally from Niedersachsen, Germany, she has worked in several countries including Ireland, Germany, and the U.S., enriching her understanding of diverse healthcare systems. After completing her studies at the Hannover Medical School in 1986, she moved to Switzerland, where she pursued her career in angiological research and treatment.

Prof. Baumgartner served for 28 years at the University Hospital Bern, including as Chair of Vascular Medicine and Full Professor. In recent years, she has led the development of Vasc Alliance AG, a specialized center for vascular malformations, emphasizing individualized patient care in a collaborative, interdisciplinary environment.

Her clinical research has contributed significantly to the vascular field through more than 350 publications spanning multiple areas of vascular disease and intervention.

Jun Li, MD

Dr. Jun Li is an Endovascular Interventional Cardiologist certified in Internal Medicine, Cardiovascular Disease, and Interventional Cardiology. Her clinical expertise includes endovascular interventions for peripheral artery disease, chronic limb threatening ischemia, mesenteric and renal artery disease, pulmonary embolism interventions, and deep venous thromboses; interventional cardiology interventions for acute coronary syndrome and cardiogenic shock; and critical care cardiology.

After graduating with two bachelor’s degrees from University of Michigan, Dearborn, Dr. Li earned her medical degree at the University of Michigan Medical School, Ann Arbor. At University Hospitals Cleveland Medical Center, OH, she completed an internal medicine residency, as well as fellowships in General Cardiology, Interventional Cardiology, and Advanced Interventional Cardiology in Endovascular therapies. In the University Hospitals Harrington Heart and Vascular Institute, she has grown in her capacity as Co-Director of the Vascular Center and Co-Director of the Pulmonary Embolism Response Team.

Dr. Li has authored more than 45 original publications, served on numerous clinical practice guidelines and consensus statements, and authored several book chapters. She has a strong presence at national and international conferences and symposia, including innumerable invited talks at American College of Cardiology (ACC), American Heart Association (AHA), Cardiovascular Innovations (CVI), Society for Cardiovascular Angiography and Interventions (SCAI), Transcatheter Cardiovascular Therapeutics (TCT), Vascular InterVentional Advances (VIVA), Japan Endovascular Treatment (JET), and Leipzig Interventional Course (LINC). With her rising prominence in the Endovascular field, she serves on multiple planning committees for national conferences.

As Fellow of the Society for Cardiovascular Angiography and Intervention (FSCAI) as well Fellow of the American College of Cardiology (FACC), Dr. Li is a dedicated and active member in multiple societal committees and serves on the editorial board for Vascular Medicine.

Tim Wittig, MD

Tim Wittig is a senior resident in the Department of Angiology at University Hospital Leipzig, where he combines clinical practice with active involvement in translational and clinical research. His primary focus lies in the field of interventional angiology, with particular emphasis on the development of differentiated and patient-specific treatment strategies for peripheral artery disease (PAD). His research interests include the optimization of endovascular procedures through advanced vessel preparation techniques and the integration of cutting-edge vascular imaging modalities to enhance diagnostic precision and procedural outcomes. Through his work, he aims to contribute to the refinement of minimally invasive therapies and improve long-term vascular health in patients with complex peripheral arterial disease.

Lindsay Machan, MD

Lindsay Machan, MD, FSIR, is an interventional radiologist at the Vancouver Hospital and Associate Professor of Radiology at the University of British Columbia, and a Fellow at the Creative Destruction Lab. In 2006 he shared the Manning Innovation Principle Award for the development of the paclitaxel eluting stent. His current research interests include mechanical methods of radiation reduction from fluoroscopy, ballistic embolic particles, and novel excipients for local drug delivery.